ARTICLE | Clinical News
Bestatin: LIBERTY2 extension study started
February 1, 2017 9:44 PM UTC
Eiger began the open-label LIBERTY2 extension study of oral Bestatin for ≥24 weeks in about 45 patients who completed the double-blind, placebo-controlled, North American Phase II LIBERTY trial, which...